Related posts
Yields and stocks climb, oil fallsFriday rally cap choppy weakMarkets weaken amid earningsThis summary was created by AI, based on 14 opinions in the last 12 months.
3M Co. is currently navigating a challenging turnaround, with a new CEO at the helm who has a strong background in managing industrials. The stock has experienced significant fluctuations, trading at a PE ratio of up to 19x, while opinions are divided on its future trajectory. Some experts believe it remains cheap given its diversified business model and potential for organic growth, especially after recent earnings beats and guidance upgrades. However, legacy issues, including ongoing lawsuits and a previously cut dividend, contribute to a cautious sentiment, prompting some analysts to urge waiting for more clarity before investing. Sentiment is mixed as the company's future hinges on cost-cutting measures and management's ability to expand operating margins successfully.
Wait. Don't enter this now. Wants to see more clarity. Shares are climbing after a long malaise and they have a new CEO. But hey have legacy problems with a chemical and a huge lawsuit, and the noise suppression technology lawsuit. These types of companies do turn around, but he'd rather pay more for more certainty.
Was upgraded today. Most calls remain sell. This is a turnaround story, but shares are cheap at 14x. They cut the dividend, now 2.8% but it remains higher than the industry average of 1.8%. They spun-off their healthcare business, so the company is simplifying. The current CEO as a good, massive track record from L3Harris and UTX. Will buy on any weakness.
It completed spinning off healthcare company Solventum today. MMM shares have been challenged by many lawsuits, including over its hearing aids, and some of its businesses have slowed. An exception is Solventum, positing positive organic growth over the past decade. Revenues were $8.2 billion in 2023, but guidance said that 2024 will be a rebuilding year. That said, it's now selling at 11x this year's earnings, cheap. Keep in mind that most spun-offs start off shaky, with those getting initial shares not wanting them. So, buy Solventum gradually over the next 6 months. As for 3M, they paid dearly to settle their lawsuits, so the worst is behind them. Also, they're cutting costs like crazy. Also, Wall Street likes the change in CEOs.
3M Co. is a American stock, trading under the symbol MMM-N on the New York Stock Exchange (MMM). It is usually referred to as NYSE:MMM or MMM-N
In the last year, 36 stock analysts published opinions about MMM-N. 12 analysts recommended to BUY the stock. 12 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for 3M Co..
3M Co. was recommended as a Top Pick by on . Read the latest stock experts ratings for 3M Co..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
36 stock analysts on Stockchase covered 3M Co. In the last year. It is a trending stock that is worth watching.
On 2025-04-02, 3M Co. (MMM-N) stock closed at a price of $147.76.
He bought it at 12x PE, now at 19x. The new CEO demonstrates they can change their business.